Nautilus Biotechnology to Announce Third Quarter of Fiscal Year 2021 Financial Results on November 2, 2021
October 11 2021 - 8:00AM
Nautilus Biotechnology, Inc. (NASDAQ: NAUT; or “Nautilus”), a
company pioneering a single-molecule protein analysis platform for
quantifying the proteome, today announced it will report
financial results for the third quarter of fiscal year 2021 before
market open on Tuesday, November 2nd, 2021.
The company’s management will webcast a corresponding conference
call beginning at 5:30 a.m. Pacific Time / 8:30 a.m. Eastern Time
to discuss its results, business developments, and outlook. Live
audio of the webcast will be available on the “Investors” section
of the company website at: www.nautilus.bio.
About Nautilus Biotechnology, Inc.
Based in Seattle, Washington, Nautilus is a development stage
life sciences company creating a platform technology for
quantifying and unlocking the complexity of the proteome. Nautilus’
mission is to transform the field of proteomics by democratizing
access to the proteome and enabling fundamental advancements across
human health and medicine. To learn more about Nautilus, visit
www.nautilus.bio.
Contacts
Investors:InvestorRelations@nautilus.bio
Media:Thermal for Nautilus BiotechnologyKaustuva
DasPress@nautilus.bio
Nautilus Biotechnology (NASDAQ:NAUT)
Historical Stock Chart
From Mar 2024 to Apr 2024
Nautilus Biotechnology (NASDAQ:NAUT)
Historical Stock Chart
From Apr 2023 to Apr 2024